- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | NewAmsterdam Pharma completes $196m Series A funding for phase 3 development programme | ||
| Fr | Pfizer's XALKORI approved by FDA for ALK-positive anaplastic large cell lymphoma in children and young adults | ||
| Fr | Novartis gets FDA breakthrough therapy status for ligelizumab to treat chronic spontaneous urticaria | ||
| Do | KSQ partners with Takeda to develop immuno-oncology therapies | ||
| Mi | Bayer announces FDA accepts NDA and grants priority review for Finerenone for patients with CKD and T2D | ||
| Mi | Amneal to acquire substantially all of Kashiv Specialty Pharmaceuticals | ||
| Mi | GSK, Vir Biotechnology to evaluate neutralising Covid-19 antibody in AGILE study | ||
| Di | Russian Covid-19 vaccine Sputnik V succeeds in phase 2 trial in India | ||
| Di | Rocket Pharmaceuticals announces buildout of R&D and manufacturing facility to support development of gene therapy pipeline | ||
| Di | BeiGene announces collaboration with Novartis to develop and commercialize anti-PD-1 antibody Tislelizumab | ||
| Di | Sanofi to buy biopharmaceutical firm Kymab for up to $1.45bn | ||
| 11.01. | GSK, MMV filing for Kozenis in paediatric populations with P. vivax malaria accepted by Australian TGA | ||
| 11.01. | Pfizer says BNT162b2 vaccine is effective against new Covid strains | ||
| 11.01. | Celularity and GX Acquisition announce merger agreement to create publicly listed leader in allogeneic cellular therapy | ||
| 11.01. | Affinivax secures $226m in Series C financing to boost MAPS vaccine pipeline | ||
| 08.01. | Teva, MedinCell announce positive results for registration trial of TV-46000/mdc-IRM for patients with Schizophrenia | ||
| 08.01. | AM-Pharma enrols first patients in Covid-19 phase III trial | ||
| 08.01. | Inversago Pharma receives rare paediatric disease designation from FDA for INV-101 to treat Prader-Willi Syndrome | ||
| 08.01. | Bayer and CureVac collaborate on Covid-19 vaccine candidate | ||
| 07.01. | Xencor, MD Anderson enter collaboration to develop novel T cell-engaging bispecific antibodies for potential treatment of cancer | ||
| 07.01. | RedHill Biopharma's RHB-204 granted FDA fast track designation for NTM disease | ||
| 07.01. | Moderna gets EC conditional marketing authorisation for Covid-19 mRNA vaccine | ||
| 07.01. | Fujifilm to invest $2bn to build large-scale cell culture manufacturing site in US | ||
| 06.01. | LakePharma to manufacture Akston Biosciences' Covid-19 vaccine | ||
| 06.01. | CURE Pharmaceutical receives FDA approval for IND application for erectile dysfunction product CUREfilm Blue |
sist1
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
